Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Glenmark Pharmaceuticals Ltd.
NSE: GLENMARK
|
BSE: 532296
|
ISIN: INE935A01035
|
Industry: Pharmaceuticals
|
Mid-range Performer
1971.7000
-59.00
(
-2.91
%)
NSE
Sep 26, 2025
15:31 PM
54.58% Gain from 52W Low
Volume:
924.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Glenmark Pharmaceuticals Ltd.
29 Jan 2016
1971.70
-2.91%
Glenmark Pharmaceuticals
Buy:
Glenmark Pharmaceuticals Ltd.
by
ICICI Securities Limited
Target: 975
ICICI Securities Limited
Geojit BNP Paribas increased Accumulate price target of Glenmark Pharmaceuticals Ltd. to 2306.0 on 09 Sep, 2025.
More from Glenmark Pharmaceuticals Ltd.
Recommended
The new H1B fee: Who will it hurt the most?
The Baseline |
26 Sep 2025, 05:06PM
Five Interesting Stocks Today - September 26, 2025
The Baseline |
26 Sep 2025, 04:56PM
Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals
|
29 Jun 2020